Pfizer’s experimental drug, ponsegromab, has shown positive results in treating cancer cachexia, a life-threatening condition that causes weight loss in cancer patients. The drug could become the first approved treatment for this condition in the US, potentially saving many lives. Meanwhile, Moderna and Merck are also making strides in cancer treatment with their experimental cancer vaccine and immunotherapy drug combination. Mainz Biomed is advancing early cancer detection with its ColoAlert colorectal cancer test, emphasizing the importance of early screening.